190 related articles for article (PubMed ID: 35853092)
1. The effect of a non-tobacco-based nicotine pouch on mucosal lesions caused by Swedish smokeless tobacco (snus).
Alizadehgharib S; Lehrkinder A; Alshabeeb A; Östberg AK; Lingström P
Eur J Oral Sci; 2022 Aug; 130(4):e12885. PubMed ID: 35853092
[TBL] [Abstract][Full Text] [Related]
2. Oral mucosal changes and nicotine disposition in users of Swedish smokeless tobacco products: a comparative study.
Andersson G; Björnberg G; Curvall M
J Oral Pathol Med; 1994 Apr; 23(4):161-7. PubMed ID: 8046653
[TBL] [Abstract][Full Text] [Related]
3. Chemical characterization of tobacco-free "modern" oral nicotine pouches and their position on the toxicant and risk continuums.
Azzopardi D; Liu C; Murphy J
Drug Chem Toxicol; 2022 Sep; 45(5):2246-2254. PubMed ID: 34034614
[TBL] [Abstract][Full Text] [Related]
4. The Correlation of Swedish Snus, Nicotine Pouches and Other Tobacco Products with Oral Mucosal Health and Salivary Biomarkers.
Miluna S; Melderis R; Briuka L; Skadins I; Broks R; Kroica J; Rostoka D
Dent J (Basel); 2022 Aug; 10(8):. PubMed ID: 36005252
[TBL] [Abstract][Full Text] [Related]
5. Pharmacokinetic Comparison of a Novel Non-tobacco-Based Nicotine Pouch (ZYN) With Conventional, Tobacco-Based Swedish Snus and American Moist Snuff.
Lunell E; Fagerström K; Hughes J; Pendrill R
Nicotine Tob Res; 2020 Oct; 22(10):1757-1763. PubMed ID: 32319528
[TBL] [Abstract][Full Text] [Related]
6. Harmful and potentially harmful constituents (HPHCs) in two novel nicotine pouch products in comparison with regular smokeless tobacco products and pharmaceutical nicotine replacement therapy products (NRTs).
Back S; Masser AE; Rutqvist LE; Lindholm J
BMC Chem; 2023 Mar; 17(1):9. PubMed ID: 36869349
[TBL] [Abstract][Full Text] [Related]
7. Increased pouch sizes and resulting changes in the amounts of nicotine and tobacco-specific N-nitrosamines in single pouches of Camel Snus and Marlboro Snus.
Stepanov I; Jensen J; Biener L; Bliss RL; Hecht SS; Hatsukami DK
Nicotine Tob Res; 2012 Oct; 14(10):1241-5. PubMed ID: 22259150
[TBL] [Abstract][Full Text] [Related]
8. Reduction in nicotine intake and oral mucosal changes among users of Swedish oral moist snuff after switching to a low-nicotine product.
Andersson G; Axéll T; Curvall M
J Oral Pathol Med; 1995 Jul; 24(6):244-50. PubMed ID: 7562659
[TBL] [Abstract][Full Text] [Related]
9. Factors effecting the induction of rat forestomach hyperplasia induced by Swedish oral smokeless tobacco (snus).
Joksić G; Rutqvist LE; Mićić M; Tričković JF; Nilsson R
Regul Toxicol Pharmacol; 2019 Jun; 104():21-28. PubMed ID: 30844416
[TBL] [Abstract][Full Text] [Related]
10. Effect of smokeless tobacco (snus) on smoking and public health in Sweden.
Foulds J; Ramstrom L; Burke M; Fagerström K
Tob Control; 2003 Dec; 12(4):349-59. PubMed ID: 14660766
[TBL] [Abstract][Full Text] [Related]
11. [Smokeless tobacco].
Underner M; Perriot J; Peiffer G
Presse Med; 2012 Jan; 41(1):3-9. PubMed ID: 21840161
[TBL] [Abstract][Full Text] [Related]
12. Systemic Toxicity of Smokeless Tobacco Products in Mice.
Malovichko MV; Zeller I; Krivokhizhina TV; Xie Z; Lorkiewicz P; Agarwal A; Wickramasinghe N; Sithu SD; Shah J; O'Toole T; Rai SN; Bhatnagar A; Conklin DJ; Srivastava S
Nicotine Tob Res; 2019 Jan; 21(1):101-110. PubMed ID: 30085294
[TBL] [Abstract][Full Text] [Related]
13. [Adverse effects of Swedish smokeless tobacco "snus"].
Wickholm S; Lahtinen A; Ainamo A; Rautalahti M
Duodecim; 2012; 128(10):1089-96. PubMed ID: 22724324
[TBL] [Abstract][Full Text] [Related]
14. Characteristics of "American Snus" and Swedish Snus Products for Sale in Massachusetts, USA.
Seidenberg AB; Ayo-Yusuf OA; Rees VW
Nicotine Tob Res; 2018 Jan; 20(2):262-266. PubMed ID: 28003512
[TBL] [Abstract][Full Text] [Related]
15. Snus (Swedish smokeless tobacco) use and risk of stroke: pooled analyses of incidence and survival.
Hansson J; Galanti MR; Hergens MP; Fredlund P; Ahlbom A; Alfredsson L; Bellocco R; Engström G; Eriksson M; Hallqvist J; Hedblad B; Jansson JH; Pedersen NL; Trolle Lagerros Y; Ostergren PO; Magnusson C
J Intern Med; 2014 Jul; 276(1):87-95. PubMed ID: 24548296
[TBL] [Abstract][Full Text] [Related]
16. Randomised clinical trial of snus versus medicinal nicotine among smokers interested in product switching.
Hatsukami DK; Severson H; Anderson A; Vogel RI; Jensen J; Broadbent B; Murphy SE; Carmella S; Hecht SS
Tob Control; 2016 May; 25(3):267-74. PubMed ID: 25991608
[TBL] [Abstract][Full Text] [Related]
17. Randomized Trial to Compare Smoking Cessation Rates of Snus, With and Without Smokeless Tobacco Health-Related Information, and a Nicotine Lozenge.
Nelson PR; Chen P; Battista DR; Pillitteri JL; Shiffman S
Nicotine Tob Res; 2019 Jan; 21(1):88-94. PubMed ID: 29373698
[TBL] [Abstract][Full Text] [Related]
18. Multi-endpoint in vitro toxicological assessment of snus and tobacco-free nicotine pouch extracts.
Yu F; Bishop E; Miazzi F; Evans R; Smart D; Breheny D; Thorne D
Mutat Res Genet Toxicol Environ Mutagen; 2024 Apr; 895():503738. PubMed ID: 38575247
[TBL] [Abstract][Full Text] [Related]
19. Use of Swedish smokeless tobacco during pregnancy: A systematic review of pregnancy and early life health risk.
Brinchmann BC; Vist GE; Becher R; Grimsrud TK; Elvsaas IØ; Underland V; Holme JA; Carlsen KCL; Kreyberg I; Nordhagen LS; Bains KES; Carlsen KH; Alexander J; Valen H
Addiction; 2023 May; 118(5):789-803. PubMed ID: 36524899
[TBL] [Abstract][Full Text] [Related]
20. Acute effects of snus in never-tobacco users: a pilot study.
Ozga JE; Felicione NJ; Elswick D; Blank MD
Am J Drug Alcohol Abuse; 2018; 44(1):113-119. PubMed ID: 27929684
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
